Optomed PlcStock Exchange Release2 November 2023 at 10.00, Helsinki
Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding
change in holdings
Optomed Plc (“Optomed” or the “Company”) has received a notification in
accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act
(as amended, the “SMA”) from Universal-Investment-Gesellschaft mit beschränkter
Haftung (“Notifier”). According to the notification, the total holdings in
Optomed shares and votes held by Notifier is 4.98 per cent of all of the
registered shares in Optomed on 31 October 2023.
The total number of the Company's registered shares amounts to 18,130,397
shares. Each share entitles to one vote.
The total position of Notifier subject to the notification:
+----------------+----------+------------------+-----+----------------------+
| |% of |% of shares and |Total|Total number of shares|
| |shares and|voting rights |of |and voting rights of |
| |voting |through financial |both |issuer |
| |rights |instruments (total|in % | |
| |(total |of B) |(A+B)| |
| |of A) | | | |
+----------------+----------+------------------+-----+----------------------+
|Resulting |4.98 % |- |4.98 |18130 397 |
|situation on the| | |% | |
|date on | | | | |
|which threshold | | | | |
|was crossed or | | | | |
|reached | | | | |
+----------------+----------+------------------+-----+----------------------+
|Position of |7.49 % |- |7.49 | |
|previous | | |% | |
|notification | | | | |
|(if applicable) | | | | |
+----------------+----------+------------------+-----+----------------------+
Notified details of the resulting situation on the date on which the threshold
was crossed or reached:
A: Shares and voting rights
+------------+-----------------+----------------+-----------------+-----------+
|Class/type |Number of shares and voting rights|% of shares and voting rights|
|of shares | | |
| | | |
|ISIN code | | |
+------------+-----------------+----------------+-----------------+-----------+
|Direct |Indirect |Direct |Indirect |
|(SMA 9:5) |(SMA 9:6 and 9:7)|(SMA 9:5) |(SMA 9:6 and 9:7)|
+------------+-----------------+----------------+-----------------+-----------+
|FI4000410881|- |903202 | |4.98 % |
+------------+-----------------+----------------+-----------------+-----------+
|SUBTOTAL A |903 202 |4.98 % |
+------------+-----------------+----------------+-----------------+-----------+
Information in relation to the person subject to the notification obligation as
contained in the notification
The complete chain of controlled undertakings through which the shares, voting
rights and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity:
+--------------------+-----------+-----------------------------+------+
|Name |% of shares|% of shares and voting rights|Total |
| |and voting |through financial instruments|of |
| |rights | |both |
+--------------------+-----------+-----------------------------+------+
|Universal-Investment|- |- |- |
|-Gesellschaft mit | | | |
|beschränkter Haftung| | | |
+--------------------+-----------+-----------------------------+------+
|Universal-Investment|4.98 % |- |4.98 %|
|-Luxembourg S.A | | | |
+--------------------+-----------+-----------------------------+------+
| |- |- |- |
+--------------------+-----------+-----------------------------+------+
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com, +358(0)50562 4077.
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld fundus cameras with
software and artificial intelligence with the aim to transform the diagnostic
process of blinding eye diseases, such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries.
www.optomed.com